EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules

Sanjib Sarkar, Mir Ekbal Kabir, Jatin Kalita, Prasenjit Manna iD

ChemBioChem · 03.04.2023 · 24 (7)

DOI: 10.1002/cbic.202200672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 10.03.2023. Verfasst von Sanjib Sarkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, 785006, Assam, India. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 192 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesoporous silica nanoparticles (MSNs) are promising nanomaterials that are widely used in biomedical applications like drug delivery, diagnosis, bio‐sensing and cell tracking. MSNs have been investigated meticulously in the drug‐delivery field due to their unique chemical and pharmacokinetic properties, such as highly ordered mesopores, high surface area and pore volume, tuneable pore size, stability, surface functionalisation, and biocompatibility. MSN‐based nanocomposites have been used to deliver therapeutic molecules like insulin, GLP‐1, exenatide, DPP‐4 inhibitor and plasmid‐containing GLP‐1 genes for managing diabetes mellitus for the last decade. The functionalisation properties of MSNs make them substantially capable of the co‐delivery, controlled delivery and stimuli‐responsive delivery of antidiabetic drugs. This review focuses on the delivery of antidiabetic therapeutics with special emphasis on the functionalisation of MSNs and stimuli‐responsive delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxideNanoparticlesHypoglycemic AgentsPorosityDrug Delivery SystemsDrug Carriers

Stichwörter der Autor:innen

antidiabetic moleculesdiabetes mellitusdrug deliverymesoporous silica nanoparticlesstimuli-responsive delivery

Substanzen

Silicon DioxideHypoglycemic AgentsDrug Carriers

Autor:innen und Institutionen

  • Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, 785006, Assam, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Center for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, 785006, Assam, India.

ORCID-Profile: Prasenjit Manna

Zitieren

APA

Sarkar, S., Ekbal Kabir, M., Kalita, J., & Manna, P. (2023). Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules. ChemBioChem, 24(7). https://doi.org/10.1002/cbic.202200672

Vancouver

Sarkar S, Ekbal Kabir M, Kalita J, Manna P. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules. ChemBioChem. 2023;24(7). doi:10.1002/cbic.202200672

BibTeX
@article{Sarkar2023,
  author = {Sarkar, Sanjib and Ekbal Kabir, Mir and Kalita, Jatin and Manna, Prasenjit},
  title = {Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules},
  journal = {ChemBioChem},
  year = {2023},
  volume = {24},
  number = {7},
  doi = {10.1002/cbic.202200672}
}
Kostenlos starten →